[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2005, 31(4) 221-222 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�ݸ˾�,����
������
���������������
���鲨
�ź�
PubMed
Article by
Article by

�����ݸ˾��������

���鲨, �ź�

�������ϴ�ѧ������һҽԺƤ����, 510630

ժҪ��

�����Dz�����,������ز������䷢���뷢չ���̡��ò����ߵ������ݸ˾���Ⱦ�ʽ������˸�,�����ݸ˾����ڶ��غͻ����������ĸ�����֢���ʿ��ܵ��¾����ǵķ����ͷ�չ�����������ݸ˾�������ѧ���ԡ�������Ƿ����ͷ�չ�Ĺ�ϵ�����Ƶ�Ӱ���Լ����ܵ����û��ơ�

�ؼ����� �ݸ˾�,����   ������  

Abstract:

Keywords:
�ո����� 2004-09-02 �޻�����  ����淢������  
DOI:
������Ŀ:

�㶫ʡ�Ƽ��ƻ���Ŀ����(���Ƽ���[2001]281��)

ͨѶ����:
���߼��:

�ο����ף�
[1] Millikan LE. Rosacea as an inflammatory disorder: a unifying theory?Cutis, 2004, 73:5-8.
[2] Gurer MA, Erel A, Erbas D, et al. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol, 2002, 41:768-770.
[3] Sharma VK, Lynn A, Kaminski M, et al. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol, 1998,93:220-222.
[4] Rebora AE. Helicobacter pylori and rosacea. J Eur Acad Dermatol Venereol, 2000, 14:344.
[5] Argenziano G, Donnarumma G, Iovene MR, et al. Incidence of antiHelicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol, 2003, 42:601-604.
[6] Bonamigo RR, Leite CS, Wagner M, et al. Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association. J Eur Acad Dermatol Venereol, 2000, 14:424-425.
[7] Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol, 2002, 16:328-333.
[8] Jones MP, Knable AL Jr, White MJ, et al. Helicobacter pylori in rosacea: lack of an association. Arch Dermatol, 1998, 134:511.
[9] Diaz C, OCallaghan CJ, Khan A, et al. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol, 2003, 83:282-286.
[10] Neubert U, Jansen TH, Plewig G. Serum antibodies to helicobacter pylori in rosacea patients. J Dermatol Sci, 1998, 16:199.
[11] Shalita A, Leyden J. Mechanism-based selection of pharmacologic agents for rosacea. Cutis,2004, 73:15-18.
[12] Son SW, Kim IH, Oh CH, et al. The response of rosacea to eradication of Helicobacter pylori. Br J Dermatol, 1999, 140:984-985.
[13] Mayr-Kanhauser S, Kranke B, Kaddu S, et al. Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. Eur J Gastroenterol Hepatol,2001, 13:1379-1383.
[14] Bamford JT, Tilden RL, Blankush JL, et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol, 1999,135:659-663.
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־